Digital health publisher Everyday Health announced last week that Cologuard, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer, is among the winners for the for the 2nd Annual Everyday Health Awards for Innovation.

The Everyday Health Awards for Innovation go to services and technologies that are "dedicated to improving overall health and wellbeing."

"These awards continue to bring the most inventive and creative digital health technologies and services to the forefront," said Everyday Health Executive Vice President and Chief Operating Officer Paul Slavin in a release "Each of the winners demonstrated an incredible understanding about where the digital health marketplace is going and how we can propel it forward."

For more information on the Everyday Health Award for Innovation, view the official news release.